June 22, 2025

See all results

Balancing the Risks and Benefits of Medications

Newsletter WEBINARS DONATE

ABOUT
ARTICLES
Isabella
INVESTIGATING GENERICS: America’s Overlooked Drug Crisis
FDA SIDE EFFECTS UPDATE: Gabapentin and Pregabalin Withdrawal Risks
Medical Journals Have Flaws, But Government Oversight Isn’t the Fix
VIDEOS
VIDEOS

Isabella
INVESTIGATING GENERICS: America’s Overlooked Drug Crisis
FDA SIDE EFFECTS UPDATE: Gabapentin and Pregabalin Withdrawal Risks
Medical Journals Have Flaws, But Government Oversight Isn’t the Fix
Unannounced Inspections of Drug Manufacturers Could Improve Drug Safety — If It Actually Happens
PODCAST
PODCAST

Preventable Illnesses: Lifestyle Choices Over Medication

Childhood Asthma and Obesity: The Road to Resilience

Food As Fuel: Managing Sugar Cravings to Fight Inflammation

Creativity in Veganism, and Discovering Vegan Life Balance

Preventative Senior Fitness, Super-Agers, and Trusting Your Body
INFOGRAPHICS

Login / Signup
Search

Meds By Condition

Multiple Sclerosis Drugs

All

Zinbryta

Latest

Latest
Oldest
Random
A to Z

Multiple Sclerosis Drugs

Multiple Sclerosis Drug, Lemtrada, Restricted in Europe

multiple sclerosis

Multiple Sclerosis Drug, Lemtrada, Restricted in Europe

Medshadow Staff

Multiple Sclerosis Drug Lemtrada

multiple sclerosis

FDA Warns About Stroke With Multiple Sclerosis Drug Lemtrada

MS Drug Pulled from Market Worldwide

multiple sclerosis

MS Drug Pulled from Market Worldwide

FDA

Quick Hits: FDA Approves New Drug for MS, Diabetes & More

MS Drug May Boost Risk of Some Types of Cancer

multiple sclerosis

MS Drug May Boost Risk of Some Types of Cancer

New Multiple Sclerosis Drug - Risk vs. Benefit

multiple sclerosis

New Multiple Sclerosis Drug – Risk vs. Benefit

Suzanne B. Robotti

ABOUT MEDSHADOW

Medications have many benefits, but it’s essential to know how to balance these against their potential side effects. MedShadow is a nonprofit foundation that focuses on the safest ways to take over-the-counter (OTC) and prescription (Rx) medications. Our name derives from the fact that side effects can sometimes be difficult to recognize, which is why we work to illuminate and explain medication reactions that may be minimized or obscured.

We also help people factor in integrative health and medicine options and provide information about lifestyle changes to optimize one’s health. Whatever decision a person makes, our goal is to be supportive.

At MedShadow, our mission is to provide independent, evidence-and science-based information. Our service and investigative journalism enables people to make informed decisions and we strive to stimulate public conversation aimed at reforming the drug manufacturing processes to ensure that we are all better protected.

We do not receive any financial support from the pharmaceutical or supplement industries and we require that all our staff, writers, advisors and other partners also be free from any remunerative relationships with such companies.

SERVICES

ACCOUNT
- Become an Insider
- Login
ABOUT
ARTICLES
PODCAST
VIDEOS
INFOGRAPHICS
CONTACT US

Balancing the Risks and Benefits of Medications

Copyright © 2025, MedShadow Foundation. All rights reserved. MedShadow Foundation is a registered 501(c)(3) non-profit organization. MedShadow does not accept advertising or contributions from pharmaceutical companies, medical device manufacturers or political action organizations. This site complies with the HONcode standard for trustworthy health information.

TERMS

ABOUT
ARTICLES
VIDEOS
PODCAST
INFOGRAPHICS

Newsletter WEBINARS DONATE

Newsletter WEBINARS JOIN

Start typing to see results or hit ESC to close

FDA side effects depression Opioids cancer

See all results

Username

Password

Remember Me

Create an account

Enter username or email

Cancel

x

Webinar Popup

WEBINAR #1 OF A SERIES JUNE 25, 4:00-5:30 PM ET

Investigating Generic Drugs: How Poor Quality Generics Cause Harm

REGISTER NOW

Katherine EbanJournalist and Author,
Bottle of Lies
David LightCo-founder and President,
Valisure
Joe GraedonPresident,
The People’s Pharmacy
Suzanne Robotti,Founder and President,
MedShadow Foundation